Harold Ruf - 09 Jun 2026 Form 4 Insider Report for ORTHOPEDIATRICS CORP (KIDS)

Reporting relationship: Director
Issuer ticker: KIDS
Reported as of: 09 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 09:49:32 UTC
Prior SEC filing: 28 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Daniel J. Gerritzen, Attorney-in-Fact

Key filing fact

Harold Ruf filed Form 4 for ORTHOPEDIATRICS CORP (KIDS) on 10 Jun 2026.

Key facts

This page summarizes Harold Ruf's Form 4 filing for ORTHOPEDIATRICS CORP (KIDS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jun 2026, 09:49.

Change

Previous filing in this sequence was filed on 28 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001719213 Primary reporting owner

Ruf Harold

Relationship: Director
Address: C/O ORTHOPEDIATRICS CORP., 2850 FRONTIER DRIVE, WARSAW
Signature: /s/ Daniel J. Gerritzen, Attorney-in-Fact
Signature date: 10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KIDS transaction

Common Stock

Award

Transaction value
Shares: +11,436
Change %: +136%
Price: $0.000000^*
Shares after: 19,837
Date: 09 Jun 2026
Ownership: Direct
Footnotes: F1

KIDS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,247
Date: 09 Jun 2026
Ownership: See Footnote
Footnotes: F2, F3

KIDS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,400
Date: 09 Jun 2026
Ownership: See Footnote
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes restricted stock awards totaling 17,037 shares.

Footnote F2

Reflects shares held by The Last Chance Legacy Trust, dated April 3, 2023, of which the reporting person is trustee and in which he is deemed to have a pecuniary interest under Section 16 regulations. The reporting person disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein.

Footnote F3

Includes restricted stock awards totaling 922 shares.

Footnote F4

Reflects shares held by the Harald Ruf Roth IRA.